Percutaneous closure of atrial septal defect type ostium secundum using the new Intrasept occluder: Initial experience

Abstract

We report the first experience obtained with the new Intrasept device. We attempted to treat 35 patients with a mean age of 43 +/- 21 years. The mean size of the defect was 17/15 mm. It was successfully closed in 31 patients. In the remaining four the device could not be stabilized because of excessive defect size. A small residual shunt was present immediately following implantation in three patients. No complications occurred during the procedure and at 6 months, 31 patients had an uneventful outcome. Only one patient had a small residual shunt. No thrombus, embolization, or device fracture was documented during a mean follow-up of 17 +/- 11 months. Percutaneous closure of ASD ostium secundum is feasible with the Intrasept device with a high success rate and very good medium-term outcome. Our initial experience and results were excellent with small to medium size defects, however, large defects (>20 mm) remain challenging.

Perforation of the aortic sinus after closure of atrial septal defects with the Atriasept occluder

“…The Atriasept has the advantages of low profile, conformity to the atrial septum, self‐centering, and retrieve ability. Initial studies showed good closure rates and virtually no complications in small and medium‐sized ASDs and patent foramen ovale [1–4].…”

Oclusão da comunicação interatrial com a nova prótese Atriasept-CARDIA: experiência inicial

“…Esse dispositivo é uma prótese de duplo disco, de baixo perfil, com mecanismo autocentrável, totalmente reposicionável e retirável, já na sua quarta versão [12][13][14] .…”